Video Library

During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.

At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...

Megan Wachlin, BSN, RN, OCN, discusses the development and implementation of an innovative case submission process for their multidisciplinary tumor board that led to a 43% time reduction, 1107 CME credits earned, and $9000 in annual savings.

Lorraine Drapek, DNP, FNP-BC, AOCNP, discusses common side effects from radiation therapy and provides guidance on managing these side effects for optimal patient care.

Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.

This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.

Donna Catamero, ANP-BC, OCN, CCRC, provides guidance for administering talquetamab and discusses strategies for monitoring and managing adverse events.

Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.

This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.

This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.